Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Express Scripts
Mallinckrodt
Johnson and Johnson
Harvard Business School

Last Updated: November 27, 2022

CLINICAL TRIALS PROFILE FOR PROCARBAZINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Procarbazine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002462 ↗ RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC Phase 3 1989-09-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with combination chemotherapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with no radiation therapy following chemotherapy in treating patients with stage III or stage IV Hodgkin's disease.
NCT00002463 ↗ Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors Completed National Cancer Institute (NCI) Phase 2 1989-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine, vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive neuroectodermal tumors.
NCT00002463 ↗ Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors Completed M.D. Anderson Cancer Center Phase 2 1989-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine, vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive neuroectodermal tumors.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Procarbazine Hydrochloride

Condition Name

Condition Name for Procarbazine Hydrochloride
Intervention Trials
Lymphoma 32
Brain and Central Nervous System Tumors 17
Hodgkin Lymphoma 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Procarbazine Hydrochloride
Intervention Trials
Lymphoma 51
Hodgkin Disease 38
Nervous System Neoplasms 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Procarbazine Hydrochloride

Trials by Country

Trials by Country for Procarbazine Hydrochloride
Location Trials
United States 381
Canada 31
Germany 16
United Kingdom 15
France 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Procarbazine Hydrochloride
Location Trials
New York 20
Ohio 18
Pennsylvania 15
Illinois 14
California 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Procarbazine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Procarbazine Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 28
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Procarbazine Hydrochloride
Clinical Trial Phase Trials
Completed 40
Active, not recruiting 13
Unknown status 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Procarbazine Hydrochloride

Sponsor Name

Sponsor Name for Procarbazine Hydrochloride
Sponsor Trials
National Cancer Institute (NCI) 25
European Organisation for Research and Treatment of Cancer - EORTC 9
Memorial Sloan Kettering Cancer Center 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Procarbazine Hydrochloride
Sponsor Trials
Other 144
NIH 26
Industry 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
Merck
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.